| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
CDK5 |
CDK5: Cell division protein kinase 5 |
17.690 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
DAB2 |
DAB2, DOC2: Disabled homolog 2 |
17.690 |
Evidence |
|
| PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
17.690 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
PTPRC |
PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ |
17.690 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
PTPRE |
PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor |
17.690 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
STAT3 |
|
17.690 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
DUSP16 |
DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 |
17.690 |
Evidence |
|
| GRK5 |
GRK5, GPRK5: G protein-coupled receptor kinase 5 |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
17.690 |
Evidence |
|
| YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
17.690 |
Evidence |
|
| HOXA10 |
HOXA10, HOX1H: Homeobox protein Hox-A10 |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
17.690 |
Evidence |
|
| CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
PRKACA |
PRKACA, PKACA: cAMP-dependent protein kinase, alpha-catalytic subunit |
17.690 |
Evidence |
|
| CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
17.690 |
Evidence |
|
| CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
RPS6KA1 |
RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 |
17.690 |
Evidence |
|
| CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
PRKCZ |
PRKCZ, PKC2: Protein kinase C zeta type |
17.690 |
Evidence |
|
| CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
17.690 |
Evidence |
|
| CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
17.690 |
Evidence |
|
| CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
CSK |
CSK: Tyrosine-protein kinase CSK |
17.690 |
Evidence |
|
| ARID4A |
ARID4A, RBBP1, RBP1: AT-rich interactive domain-containing protein 4A |
HDAC2 |
HDAC2: Histone deacetylase 2 |
17.690 |
Evidence |
|
| RBL1 |
RBL1: Retinoblastoma-like protein 1 |
CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
17.690 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
SPTBN1 |
SPTBN1, SPTB2: Spectrin beta chain, brain 1 |
17.690 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
17.690 |
Evidence |
|
| MCM3 |
MCM3: DNA replication licensing factor MCM3 |
RBL1 |
RBL1: Retinoblastoma-like protein 1 |
17.690 |
Evidence |
|
| ADRBK1 |
ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 |
DUSP6 |
DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 |
17.690 |
Evidence |
|
| ADRBK1 |
ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
17.690 |
Evidence |
|
| ADRBK1 |
ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 |
MKNK1 |
MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 |
17.690 |
Evidence |
|